Epigenetic dysregulation in neurodegenerative diseases and potential treatment

Epigenetic dysregulation in neurodegenerative diseases and potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Dades bibliogràfiques
Autor principal:	Mostofa, Golam
Altres autors:	Khan, Tanisha Tabassum Sayka
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2022
Matèries:	Epigenetics Dysregulation Methylation Acetylation Alzheimer’s disease Parkinson’s disease Huntington’s disease Epidrugs
Accés en línia:	http://hdl.handle.net/10361/17309

Ítems similars

Potential treatments for epigenetic dysregulation in neurological diseases
per: Zaman, Rubaiyat
Publicat: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
per: Dey, Manashi
Publicat: (2024)

Gene editing for neurodegenerative diseases-A review
per: Sharna, Anika Islam
Publicat: (2023)

Role of epigenetics in the development of metabolic disorders: a review
per: Mita, Tanzia Mohsin
Publicat: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
per: Alim, Abdul
Publicat: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
per: Annee, Israt Jahan
Publicat: (2023)

Role of circular RNA in neurological disease
per: Salsabil, Labiba
Publicat: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
per: Afsana, Nourin
Publicat: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
per: Ferdous, Labiba
Publicat: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
per: Chowdhury, Sariya Uzrat
Publicat: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
per: Tabassum, Nadira
Publicat: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
per: Islam, Md. Irfath
Publicat: (2023)

A review on cardiovascular development and epigenetics
per: Srity, Nafisa Alam
Publicat: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
per: Shehab, Habibul Mohsin
Publicat: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
per: Afreen, Nuraia
Publicat: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
per: Tamanna, Mst. Taskia
Publicat: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
per: Karmaker, Swastika
Publicat: (2024)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
per: Tasneem, Sadia
Publicat: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
per: Ishrat, Nowshin
Publicat: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
per: Saha, Bithi Rani
Publicat: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
per: Chowdhury, Amal
Publicat: (2024)

Marine compounds in the treatment of Alzheimer’s disease
per: Parveen, Sanjana
Publicat: (2022)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
per: Hassan, Md. Muhtaz
Publicat: (2020)

Review on: the mechanism and function of Glia in parkinson's disease
per: Abedin, Khondokar Mezbahul
Publicat: (2023)

Alzheimer's disease and marriage : an intimate account /
per: Wright, Lore K.
Publicat: (1993)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
per: Key, Nasrin Sultana
Publicat: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
per: Tasin, Md Abtahi
Publicat: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
per: Aziz, Farhin
Publicat: (2019)

Early detection of parkinson’s disease using image processing and artificial neural network
per: Rumman, Mosarrat, et al.
Publicat: (2018)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
per: Afra, Sumaiya
Publicat: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
per: Bakar, Osama Bin Abu
Publicat: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
per: Mahee, Sadique Abdal
Publicat: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
per: Islam, Md. Rakibul
Publicat: (2023)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
per: Halim, Rabea
Publicat: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
per: Aana, Afsara Sumon
Publicat: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
per: Haque, Mushfiqul
Publicat: (2019)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
per: Jahan, Nusrat
Publicat: (2023)

Infection and communicable diseases /
per: Brettle, Raymond Patrick
Publicat: (1984)

Exploring Alzheimer's disease prediction with XAI in various neural network models
per: Rahman, Quazi Ashikur, et al.
Publicat: (2022)

Exploring the potential of organic molecules in the treatment of covid-19
per: Mondol, Winifred Claire
Publicat: (2024)